We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Moderna Plans New U.S. Trial to Evaluate COVID-19 Vaccine in Adolescents
Moderna Plans New U.S. Trial to Evaluate COVID-19 Vaccine in Adolescents
Moderna is preparing to launch a new phase 2/3 trial in the U.S. to assess its promising coronavirus vaccine in adolescent participants aged 12 to 17, though it’s not yet clear when it will start enrolling volunteers.